Joseph A Sowell Iii is SVP; Chief Development Officer of HCA Healthcare, Inc.. Currently has a direct ownership of 0 shares of HCA, which is worth approximately $0. The most recent transaction as insider was on Aug 05, 2024, when has been sold 13,367 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Joseph A Sowell III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2024
SELL
Bona fide gift
-
13,367 Reduced 100.0%
0 Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$3,239,519 $326.96 p/Share
9,908 Reduced 42.57%
13,367 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
$1,310,239 $68.96 p/Share
19,000 Added 44.94%
23,275 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$618,642 $308.55 p/Share
2,005 Reduced 31.93%
4,275 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
6,280 Added 50.0%
6,280 Common Stock
Nov 14 2023
SELL
Bona fide gift
-
5,159 Reduced 100.0%
0 Common Stock
Feb 17 2023
SELL
Payment of exercise price or tax liability
$641,592 $262.84 p/Share
2,441 Reduced 32.12%
5,159 Common Stock
Feb 17 2023
BUY
Grant, award, or other acquisition
-
7,600 Added 50.0%
7,600 Common Stock
Oct 28 2022
SELL
Open market or private sale
$2,889,288 $223.18 p/Share
12,946 Reduced 100.0%
0 Common Stock
Oct 25 2022
SELL
Payment of exercise price or tax liability
$3,120,378 $214.4 p/Share
14,554 Reduced 52.92%
12,946 Common Stock
Oct 25 2022
BUY
Exercise of conversion of derivative security
$1,319,175 $47.97 p/Share
27,500 Added 50.0%
27,500 Common Stock
Aug 10 2022
SELL
Bona fide gift
-
17,051 Reduced 100.0%
0 Common Stock
Mar 11 2022
SELL
Open market or private sale
$3,099,418 $269.0 p/Share
11,522 Reduced 40.32%
17,051 Common Stock
Feb 18 2022
SELL
Payment of exercise price or tax liability
$743,529 $244.1 p/Share
3,046 Reduced 9.63%
28,573 Common Stock
Feb 18 2022
BUY
Grant, award, or other acquisition
-
7,740 Added 19.67%
31,619 Common Stock
Jan 05 2022
SELL
Payment of exercise price or tax liability
$3,069,571 $258.97 p/Share
11,853 Reduced 33.17%
23,879 Common Stock
Jan 05 2022
BUY
Exercise of conversion of derivative security
$1,121,299 $47.97 p/Share
23,375 Added 39.55%
35,732 Common Stock
Jan 04 2022
SELL
Open market or private sale
$5,754,388 $259.23 p/Share
22,198 Reduced 64.24%
12,357 Common Stock
Dec 29 2021
SELL
Payment of exercise price or tax liability
$5,312,486 $258.49 p/Share
20,552 Reduced 37.29%
34,555 Common Stock
Dec 29 2021
BUY
Exercise of conversion of derivative security
$1,589,445 $37.18 p/Share
42,750 Added 43.69%
55,107 Common Stock
Feb 18 2021
SELL
Payment of exercise price or tax liability
$551,768 $174.61 p/Share
3,160 Reduced 20.36%
12,357 Common Stock
Feb 18 2021
BUY
Grant, award, or other acquisition
-
10,147 Added 39.54%
15,517 Common Stock
JAS

Joseph A Sowell Iii

SVP; Chief Development Officer
Nashville, TN

Track Institutional and Insider Activities on HCA

Follow HCA Healthcare, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCA shares.

Notify only if

Insider Trading

Get notified when an Hca Healthcare, Inc. insider buys or sells HCA shares.

Notify only if

News

Receive news related to HCA Healthcare, Inc.

Track Activities on HCA